Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 165,500 shares, a decline of 13.4% from the May 31st total of 191,100 shares. Approximately 3.8% of the company’s stock are sold short. Based on an average daily trading volume, of 247,400 shares, the days-to-cover ratio is presently 0.7 days.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of Check-Cap in a research report on Wednesday, June 26th. They issued a “sell” rating on the stock.
Read Our Latest Research Report on CHEK
Check-Cap Price Performance
Check-Cap (NASDAQ:CHEK – Get Free Report) last released its quarterly earnings results on Wednesday, May 15th. The medical research company reported ($0.62) EPS for the quarter. As a group, equities research analysts expect that Check-Cap will post -0.68 earnings per share for the current fiscal year.
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Featured Articles
- Five stocks we like better than Check-Cap
- Which Wall Street Analysts are the Most Accurate?
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 3 Fintech Stocks With Good 2021 Prospects
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Best Aerospace Stocks Investing
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.